Skip to main content

Table 4 Clinical and laboratory data by PD- and GS-detected entheseal abnormalities

From: Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study

  PD-detected entheseal abnormalities GS-detected entheseal abnormalities GS + PD detected entheseal abnormalities
  present absent p present absent p present absent p
Agea 52 (23.5-58.3) 38 (29–45) 0.707 40 (28–56) 33.5 (24.5-38.5) 0.155 40 (28–56) 33.5 (24.5-38.5) 0.102
BMIa 22.59 (19.9-24.6) 23.24 (19.9-25.9) 0.608 23.4 (20.9-26.4) 21.9 (19.7-24.4) 0.297 23.24 (20.9-26.4) 21.87 (19.7-24.4) 0.297
Disease durationa 6 (2.3-9.5) 7 (4.5-12) 0.695 7 (4–12) 6.5 (4.5-10) 0.724 7 (4–12) 6.5 (4.5-10) 0.972
Disease flarea 2.50 (2–3.75) 3 (2–5) 0.009* 4 (2–5) 2 (1.75-53) 0.204 4 (2–5) 2 (1.75-3) 0.295
Active diseaseb 21 79 0.883 0 100 0.53 9.1 91.9 0.721
ESRa 8.5 (5.3-9.8) 10 (6–17.5) 0.224 8 (5–11) 14.5 (10–29) 0.116 8 (5–11) 14.5 (10–29) 0.196
CRPa 0.35 (0.19-075) 0.19 (0.09-0.8) 0.044* 0.19 (0.1-0.61) 0.4 (0.1-1.3) 0.116 0.19 (0.1-0.6) 0.4 (0.1-1.35) 0.796
ASCAb 15.8 84.2 0.127 78.9 21.1 0.991 30 70 0.822
pANCAb 21.4 78.6 0.476 57.1 42.9 0.022* 16 84 0.011*
Steroidsb 14.3 85.7 0.271 14.2 85.8 0.835 9.4 90.6 0.909
Anti-TNFαb 40 60 0.356 92 8 0.14 37.5 62.5 0.05
AZAb 9 91 0.005* 68.1 31.9 0.030* 23.4 76.6 0.014*
5 ASAb 40 60 0.745 41.2 58.8 0.745 39.1 60.0 0.727
  1. amedian values (interquartile ranges), Mann–Whitney U test; bpercentages (%), χ2 test
  2. PD power Doppler, GS grey scale, CRP C-reactive protein, ESR erythrocyte sedimentation rate, pANCA anti-neutrophil cytoplasmic antibodies, ASCA anti-Saccharomyces cerevisiae antibodies, AZA azathioprine, 5 ASA 5 asa compounds; *p < 0.05